We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$427M
AUM Growth
+$29.9M
Cap. Flow
-$8.69M
Cap. Flow %
-2.04%
Top 10 Hldgs %
72.29%
Holding
50
New
–
Increased
3
Reduced
37
Closed
7

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$245K
2
MSFT icon
Microsoft
MSFT
+$201K
3
SBUX icon
Starbucks
SBUX
+$28.6K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.8M
2
NVDA icon
NVIDIA
NVDA
+$1.23M
3
AMZN icon
Amazon
AMZN
+$567K
4
ISRG icon
Intuitive Surgical
ISRG
+$421K
5
LULU icon
lululemon athletica
LULU
+$367K

Sector Composition

Rank Sector Weight
1 Technology 44.07%
2 Consumer Discretionary 24.89%
3 Healthcare 18.09%
4 Communication Services 11.33%
5 Utilities 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
26
AbbVie
ABBV
$454B
$1.55M 0.36%
8,524
-633
-7% -$109K
BMY icon
27
Bristol-Myers Squibb
BMY
$128B
$1.49M 0.35%
27,442
-250
-0.9% -$12.7K
AZN icon
28
AstraZeneca
AZN
$263B
$1.27M 0.3%
9,407
-2,182
-19% -$289K
COST icon
29
Costco
COST
$422B
$1.2M 0.28%
1,641
-56
-3% -$40K
MRK icon
30
Merck
MRK
$323B
$879K 0.21%
6,663
-60
-0.9% -$7.39K
ABT icon
31
Abbott
ABT
$182B
$775K 0.18%
6,817
-317
-4% -$36.3K
JPM icon
32
JPMorgan Chase
JPM
$947B
$677K 0.16%
3,381
-145
-4% -$26.2K
JNJ icon
33
Johnson & Johnson
JNJ
$641B
$663K 0.16%
4,189
-412
-9% -$65.6K
PAYX icon
34
Paychex
PAYX
$41.1B
$638K 0.15%
5,195
-210
-4% -$25.5K
NUE icon
35
Nucor
NUE
$56.4B
$619K 0.15%
3,130
-80
-2% -$14.6K
URGN icon
36
UroGen Pharma
URGN
$2.02B
$521K 0.12%
34,701
– –
DE icon
37
Deere & Co
DE
$169B
$520K 0.12%
1,265
-65
-5% -$24.9K
CAT icon
38
Caterpillar
CAT
$402B
$491K 0.12%
1,339
-75
-5% -$24K
BA icon
39
Boeing
BA
$167B
$482K 0.11%
2,495
-124
-5% -$25.5K
ORCL icon
40
Oracle
ORCL
$345B
$300K 0.07%
2,389
– –
V icon
41
Visa
V
$689B
$289K 0.07%
1,037
-5
-0.5% -$1.38K
TGT icon
42
Target
TGT
$63.7B
$257K 0.06%
1,450
– –
IDXX icon
43
Idexx Laboratories
IDXX
$43.9B
$214K 0.05%
397
-25
-6% -$13.7K
BCRX icon
44
BioCryst Pharmaceuticals
BCRX
$2.43B
– –
-56,600
Closed -$339K
DUK icon
45
Duke Energy
DUK
$100B
– –
-2,080
Closed -$202K
EOLS icon
46
Evolus
EOLS
$407M
– –
-25,070
Closed -$264K
PFE icon
47
Pfizer
PFE
$141B
– –
-7,755
Closed -$223K
PLSE icon
48
Pulse Biosciences
PLSE
$2.27B
– –
-10,325
Closed -$126K
SMMT icon
49
Summit Therapeutics
SMMT
$10.5B
– –
-24,059
Closed -$62.8K
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
– –
-10,609
Closed -$10.2K
1
2

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $417M AUM 16.82% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return

Bender Robert & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Bender Robert & Associates held 50 positions worth $427M, up 7.5% from $397M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bender Robert & Associates's Q1 2024 filing shows 3 increased, 37 reduced and 7 closed positions. The largest sale was Apple, an estimated $1.8M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates added most to Palo Alto Networks in Q1 2024, an estimated $245K increase.
  • Bender Robert & Associates's biggest Q1 2024 reduction was Apple, cutting an estimated $1.8M.
  • Bender Robert & Associates fully exited BioCryst Pharmaceuticals in Q1 2024, selling an estimated $339K.
  • Bender Robert & Associates's ten largest holdings make up 72% of its $427M portfolio in Q1 2024.
  • Bender Robert & Associates opened 0 new positions and closed 7 in Q1 2024.
  • Bender Robert & Associates's portfolio value rose 7.5% quarter-over-quarter to $427M.

Based on Bender Robert & Associates's 13F filing for Q1 2024, filed 23 Apr 2024.